JAMA+ Trials

@JAMAplusTrials

Highlighting the implications and innovations of clinical trial research to advance evidence-based medicine and public health.

JAMA+ Trials
@JAMAplusTrials
Aug 3
💬 Editorial: #Deescalation and discontinuation trials assess whether less care can achieve noninferior outcomes while reducing adverse effects, patient burden, and societal costs. ja.ma/4fN0SUK
1
JAMA+ Trials
@JAMAplusTrials
Aug 3
RCT: Zilucoplan, a complement inhibitor targeting C5, did not impact the progression in patients with amyotrophic lateral sclerosis (#ALS). ja.ma/3TPzRZi
JAMA+ Trials
@JAMAplusTrials
Aug 3
Looking for the latest practice-changing evidence? Explore the JAMA+ Trials Theme of the Month, featuring a curated selection of clinical trials and research that highlight key developments in medicine.
Trial Theme of the Month
From jamanetwork.com
JAMA+ Trials
@JAMAplusTrials
Aug 3
RCT: Among preterm infants with PDA, expectant management vs pharmacologic closure showed no difference in the composite outcome of death or BPD at 36 weeks and a lower risk of mortality compared with pharmacologic treatment. ja.ma/45BeYnc
JAMA+ Trials
@JAMAplusTrials
Jun 24
JAMA+ Trials: In a RCT involving more than 1500 participants, investigators evaluated whether audiovisual enhancements to electronic consent increased consent rates or improved comprehension compared with text-only formats. 📖 From @JAMANetworkOpen: ja.ma/3QQDFsc
1